BevacizumabReferencesCitationsHurwitz H, et al. (2004). Bevacizumab plus irinotecan,
fluorouracil, and leucovorin for metastatic colorectal cancer. New England Journal of Medicine, 350(23):
2335–2342. U.S. Food and Drug Administration (2006). FDA approves new combination therapy for lung cancer. FDA News. Available online: http://www.fda.gov/bbs/topics/NEWS/2006/NEW01488.html.
| |